AML1/ETO sensitizes via TRAIL acute myeloid leukemia cells to the pro-apoptotic effects of hypoxia

Cell Death and Disease

Volumn 4, Issue 3, 2013, Pages

  Barbetti, V ^a   Tusa, I ^a   Cipolleschi, M G ^a   Rovida, E ^a   Sbarba, P Dello ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

AML; AML1 ETO; Apoptosis; Hypoxia; TRAIL

Indexed keywords

CASPASE 8; DEATH RECEPTOR 5; DNA METHYLTRANSFERASE 1; IMMUNOGLOBULIN G ANTIBODY; PROCASPASE 3; PROCASPASE 8; PROCASPASE 9; TRANSCRIPTION FACTOR RUNX1; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; ANTIBODY; ONCOPROTEIN; OXYGEN; RUNX1 PROTEIN, HUMAN; RUNX1T1 PROTEIN, HUMAN; TNFSF10 PROTEIN, HUMAN; TRANSCRIPTION FACTOR;

ACUTE GRANULOCYTIC LEUKEMIA; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL CYCLE PHASE; CELL LYSATE; CELL POPULATION; CELL VIABILITY; CHROMATIN IMMUNOPRECIPITATION; CONSENSUS SEQUENCE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HYPOXIA; LEUKEMIA CELL LINE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; CELL CYCLE CHECKPOINT; CELL HYPOXIA; DRUG ANTAGONISM; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PATHOLOGY; PROMOTER REGION; PROTEIN BINDING; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ANTIBODIES; APOPTOSIS; BASE SEQUENCE; CASPASE 8; CELL CYCLE CHECKPOINTS; CELL HYPOXIA; CELL LINE, TUMOR; CORE BINDING FACTOR ALPHA 2 SUBUNIT; GENE EXPRESSION REGULATION, LEUKEMIC; HUMANS; LEUKEMIA, MYELOID, ACUTE; MOLECULAR SEQUENCE DATA; OXYGEN; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS; SIGNAL TRANSDUCTION; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 84875910235     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2013.49     Document Type: Article

References (35)

1. Wang J, Hoshino T, Redner RL, Kajigaya S, Liu JM. Protein ETO, fusion partner in t(8;21) acute myeloid leukemia, represses transcription by interaction with the human N-CoR/ mSin3/HDAC1complex. Proc Natl Acad Sci USA 1998; 95: 10860-10865.
2. Downing Jr. The AML1-ETO chimaeric transcription factor in acute myeloid leukaemia: Biology and clinical significance. Br J Haematol 1999; 106: 296-308.
3. Gardini A, Cesaroni M, Luzi L, Okumura AJ, Biggs JR, Minardi SP et al. M. AML1/ETO oncoprotein is directed to AML1 binding regions and co-localizes with AML1 and HEB on its targets. PLoS Genet 2008; 4: E1000275.
4. Licht JD. AML1 and the AML1-ETO fusion protein in the pathogenesis of t(8;21) AML. Oncogene 2001; 20: 5660-5679.
5. Cipolleschi MG, Dello Sbarba P, Olivotto M. The role of hypoxia in the maintenance of hematopoietic stem cells. Blood 1993; 82: 2031-2037.
6. Giuntoli S, Rovida E, Barbetti V, Cipolleschi MG, Olivotto M, Dello Sbarba P. Hypoxia suppresses BCR/Abl and selects imatinib-insensitive progenitors within clonal CML populations. Leukemia 2006; 20: 1291-1293.
7. Giuntoli S, Rovida E, Gozzini A, Barbetti V, Cipolleschi MG, Olivotto M et al. P. Severe hypoxia defines heterogeneity and selects highly immature progenitors within clonal erythroleukemia cells. Stem Cells 2007; 25: 1119-1125.
8. Cipolleschi MG, Rovida E, Ivanovic Z, Praloran V, Olivotto M, Dello Sbarba P. The expansion of murine bone marrow cells preincubated in hypoxia as an in vitro indicator of their marrow-repopulating ability. Leukemia 2000; 14: 735-739.
9. Shroff EH, Snyder C, Chandel NS. Role of Bcl-2 family members in anoxia-induced cell death. Cell Cycle 2007; 6: 807-809.
10. Han SH, Kim M, Park K, Kim TH, Seol DW. Blockade of processing/activation of caspase3 by hypoxia. Biochem Biophys Res Commun 2008; 375: 684-688.
11. Kim M, Park SY, Pai HS, Kim TH, Billiar TR, Seol DW. Hypoxia inhibits tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by blocking Bax translocation. Cancer Res. 2004; 64: 4078-4081.
12. Greljer AE, van der Wall E. The role of hypoxia inducible factor 1 (HIF-1) in hypoxia induced apoptosis. J Clin Pathol 2004; 57: 1009-1014.
13. Secchiero P, Zauli G. Tumor-necrosis-factor-related apoptosis inducing ligand and the regulation of hematopoiesis. Curr Opin Hematol 2008; 15: 42-48.
14. Manzo F, Nebbioso A, Miceli M, Conte M, De Bellis F, Carafa V et al. L. TNF-related apoptosis-inducing ligand: Signalling of a 'smart' molecule. Int J Biochem Cell Biol 2009; 41: 460-466.
15. Noteborn MH. Proteins selectively killing tumor cells. Eur J Pharmacol 2009; 625: 165-173.
16. Lu Y, Xu YB, Yuan TT, Song MG, Lubbert M, Fliegauf M et al. GQ. Inducible expression of AML1-ETO fusion protein endows leukemic cells with susceptibility to extrinsic and intrinsic apoptosis. Leukemia 2006; 20: 987-993.
17. Barbetti V, Gozzini A, Rovida E, Morandi A, Spinelli E, Fossati G et al. V. Selective antileukaemic activity of low-dose histone deacetylase inhibitor ITF2357 on AML1/ETOpositive cells. Oncogene 2008; 27: 1767-1778.
18. Rovida E, Gozzini A, Barbetti V, Giuntoli S, Santini V, Dello Sbarba P. The c-Jun-Nterminal- Kinase inhibitor SP600125 enhances the butyrate derivative D1-induced apoptosis via caspase 8 activation in Kasumi-1 t(8;21) acute myeloid leukaemia cells. Br J Haematol 2006; 135: 653-659.
19. Weinmann M, Marini P, Jendrossek V, Betsch A, Goecke B, Budach W et al. Influence of hypoxia on TRAIL-induced apoptosis in tumor cells. Int J Radiat Oncol Biol Phys 2004; 58: 386-396.
20. Gobbi G, Masselli E, Micheloni C, Nouvenne A, Russo D, Santi P et al. P. Hypoxia-induced down-modulation of PKCepsilon promotes trail-mediated apoptosis of tumor cells. Int J Oncol 2010; 37: 719-729.
21. Lee YJ, Lee KH, Kim HR, Jessup JM, Seol DW, Kim TH et al. YK. Sodium nitroprusside enhances TRAIL-induced apoptosis via a mitochondria-dependent pathway in human colorectal carcinoma CX-1 cells. Oncogene 2001; 20: 1476-1485.
22. Lee YJ, Moon MS, Kwon SJ, Rhee JG. Hypoxia and low glucose differentially augments TRAIL-induced apoptotic death. Mol Cell Biochem 2005; 270: 89-97.
23. Park SY, Billiar TR, Seol DW. Hypoxia inhibition of apoptosis induced by tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). Biochem Biophys Res Commun 2002; 291: 150-153.
24. Kim M, Park SY, Pai HS, Kim TH, Billiar TR, Seol DW. Hypoxia inhibits tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by blocking Bax translocation. Cancer Res 2004; 64: 4078-4081.
25. Nagaraj NS, Vigneswaran N, Zacharias W. Hypoxia inhibits TRAIL-induced tumor cell apoptosis: Involvement of lysosomal cathepsins. Apoptosis 2007; 12: 125-139.
26. Fitzgerald LD, Bailey CK, Brandt SJ, Thompson ME. BRCA1 accumulates in the nucleus in response to hypoxia and TRAIL and enhances TRAIL-induced apoptosis in breast cancer cells. FEBS J 2007; 274: 5137-5146.
27. Nijhuis EH, Poot AA, Feijen J, Vermes I. Hsp70- and p53-reponses after heat treatment and/or X-irradiation mediate the susceptibility of hematopoietic cells to undergo apoptosis. Int J Radiat Biol 2008; 84: 99-105.
28. Mayes PA, Campbell L, Ricci MS, Plastaras JP, Dicker DT, El-Deiry WS. Modulation of TRAIL-induced tumor cell apoptosis in a hypoxic environment. Cancer Biol Ther 2005; 4: 1068-1074; (ex-23).
29. Dunne J, Gascoyne DM, Lister TA, Brady HJ, Heidenreich O, Young BD. AML1/ETO proteins control POU4F1/BRN3A expression and function in t(8;21) acute myeloid leukemia. Cancer Res 2010; 70: 3985-3995.
30. Giuntoli S, Tanturli M, Di Gesualdo F, Barbetti V, Rovida E, Dello Sbarba P. Glucose availability in hypoxia regulates the selection of chronic myeloid leukemia progenitor subsets with different resistance to imatinib-mesylate. Haematologica 2011; 96: 204-212.
31. Tanturli M, Giuntoli S, Barbetti V, Rovida E, Dello Sbarba P. Hypoxia selects bortezomibresistant stem cells of chronic myeloid leukemia. PLoS One 2011; 6: E17008.
32. Asou H, Tashiro S, Hamamoto K, Osuji A, Kita K, Kamada N. Establishment of a human acute myeloid leukemia cell line (Kasumi-1) with 8;21 chromosome translocation. Blood 1991; 77: 2031-2036.
33. Larrick JW, Fischer DG, Anderson SJ, Koren HS. Characterization of a human macrophagelike cell line stimulated in vitro: A model of macrophage functions. J Immunol 1980; 125: 6-12.
34. Fliegauf M, Stock M, Berg T, Lubbert M. Williams-Beuren syndrome critical region-5/non- T-cell activation linker: A novel target gene of AML1/ETO. Oncogene 2004; 23: 9070-9081.
35. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001; 25: 402-408.